Increased Mortality Among Persons With Symptomatic Coronavirus Disease 2019 (COVID-19) During the Period of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta Variant) Predominance: Alaska, November 2020–October 2021 | Zendy

Eric Q. Mooring | Zendy; K. David Newell | Zendy; Louisa Castrodale | Zendy; Megan Tompkins | Zendy; Frank Morgan | Zendy; Joseph K. McLaughlin | Zendy

Open Access

Increased Mortality Among Persons With Symptomatic Coronavirus Disease 2019 (COVID-19) During the Period of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta Variant) Predominance: Alaska, November 2020–October 2021

Author(s) -

Eric Q. Mooring,

K. David Newell,

Louisa Castrodale,

Megan Tompkins,

Frank Morgan,

Joseph K. McLaughlin

Publication year - 2022

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciac530

Subject(s) - medicine , covid-19 , betacoronavirus , coronavirus , virology , pandemic , coronavirus infections , pneumonia , respiratory disease , severe acute respiratory syndrome , disease , outbreak , infectious disease (medical specialty) , lung

We compared the mortality risk in Alaska among persons with symptomatic coronavirus disease 2019 (COVID-19) during the period the Delta variant was predominant to the risk among those with symptomatic COVID-19 before Delta predominance. The Delta period was associated with 2.43-fold higher odds of death. Unvaccinated persons were 4.49 times more likely to die than fully vaccinated persons.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research